Capital Research & Management Co recently announced the acquisition of new stake in Riskified Ltd (NYSE:RSKD). The institutional investor has increased its shareholding in the Technology company by 48.30% to 9.19 million shares with purchase of 2.99 million shares. This fresh investment now brings its stake to 8.86% valued currently at $43.03 million. In addition, Clal Pension & Provident Funds Lt raised its holdings by 1.68 million to 3.83 million shares. And EVR Research LP has lifted its position by 58.84% or 1.12 million shares – to 3.02 million shares.
With over 0.44 million Riskified Ltd (RSKD) shares trading Friday and a closing price of $4.41 on the day, the dollar volume was approximately $1.93 million. The shares have shown a negative half year performance of -7.74% and its price on 01/12/24 lost nearly -0.90%. Currently, there are 102.08M common shares owned by the public and among those 70.39M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The top 3 mutual fund holders in Riskified Ltd are American Funds Small Cap World Fu, JNL Multi-Manager Small Cap Growt, and Allspring Common Stock Fund. American Funds Small Cap World Fu owns 9.19 million shares of the company’s stock, all valued at over $43.03 million. The company bought an additional 2.99 million shares recently to bring their total holdings to about 8.86% of the shares outstanding. JNL Multi-Manager Small Cap Growt bought 0.44 million shares to see its total holdings expand to 1.03 million shares valued at over $4.8 million and representing 0.99% of the shares outstanding. Allspring Common Stock Fund now owns shares totaling to 0.61% of the shares outstanding.
However, the script later moved the day high at 4.5500, down -0.90%. The company’s stock has a 5-day price change of -0.23% and 12.50% over the past three months. RSKD shares are trading -5.77% year to date (YTD), with the 12-month market performance down to -16.16% lower. It has a 12-month low price of $3.48 and touched a high of $6.73 over the same period. RSKD has an average intraday trading volume of 643.22K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.84%, 4.36%, and -3.70% respectively.
Institutional ownership of Riskified Ltd (NYSE: RSKD) shares accounts for 37.62% of the company’s 102.08M shares outstanding. Mutual fund holders own 13.30%, while other institutional holders and individual stakeholders account for 44.62% and — respectively.
It has a market capitalization of $704.59M and a beta (3y monthly) value of 1.29. The earnings-per-share (ttm) stands at -$0.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.63% over the week and 3.58% over the month.
Analysts forecast that Riskified Ltd (RSKD) will achieve an EPS of $0.02 for the current quarter, $0.01 for the next quarter and $0.03 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.04 while analysts give the company a high EPS estimate of $0.05. Comparatively, EPS for the current quarter was $0.03 a year ago. Earnings per share for the fiscal year are expected to increase by 40.47%, and 21.92% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 7 brokerage firm advisors rate Riskified Ltd (RSKD) as a “Moderate Buy” at a consensus score of 2.14. Specifically, 3 Wall Street analysts polled rate the stock as a buy, while 4 of the 7 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the RSKD, a number of firms have released research notes about the stock. Barclays stated their Equal Weight rating for the stock in a research note on December 14, 2023, with the firm’s price target at $5.
